iBio, Inc. (IBIO) Return on equity 2016–2025
iBio, Inc. (IBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-123.5%FY2025 · since FY2016: -98.3% → -123.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -123.5% | -6.7 pp |
| FY2024 | -116.8% | +305.9 pp |
| FY2023 | -422.7% | -343.4 pp |
| FY2022 | -79.2% | -57.9 pp |
| FY2021 | -21.4% | +7.7 pp |
| FY2020 | -29.0% | +685.3 pp |
| FY2019 | -714.3% | -614.7 pp |
| FY2018 | -99.6% | +63.4 pp |
| FY2017 | -163.0% | -64.8 pp |
| FY2016 | -98.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice